商务合作
动脉网APP
可切换为仅中文
Photo: Caiaimage/Agnieszka Olek/Getty Images
照片来源:Caiaimage/Agnieszka Olek/Getty Images
Boston-based therapeutic extended reality platform
波士顿的治疗性扩展现实平台
XRHealth
XRHealth
has acquired virtual reality digital therapeutics company
收购了虚拟现实数字治疗公司
RealizedCare
实现关怀
, which combines digital therapeutics with wraparound virtual services to supply value-based chronic care management.
,它将数字疗法与全方位的虚拟服务相结合,提供基于价值的慢性病管理。
XRHealth offers medical extended reality (XR) experiences focused on the physical and cognitive space, including immersive environments designed to reduce pain perception during medical procedures and enable occupational and physical rehabilitation, as well as cognitive training and behavioral therapy. .
XRHealth 提供专注于身体和认知领域的医疗扩展现实 (XR) 体验,包括旨在减少医疗程序期间疼痛感知的沉浸式环境,以及实现职业和物理康复、认知训练和行为治疗的功能。
The company also offers treatment environments to assist with behavioral therapy, such as PTSD, stress, addiction and obsessive-compulsive disorder (OCD).
该公司还提供治疗环境,以协助行为治疗,例如创伤后应激障碍 (PTSD)、压力、成瘾和强迫症 (OCD)。
RealizedCare, which was formed in 2023
2023年成立的RealizedCare
as a result of a merger
由于合并的结果
between VR behavioral health platform
介于VR行为健康平台之间
BehaVR
贝哈VR
and virtual chronic care-management company
和虚拟慢性病护理管理公司
Fern Health
远程健康
, is a digital care management platform for chronic pain powered by digital therapeutics.
,是一个由数字疗法驱动的慢性疼痛数字护理管理平台。
RealizedCare's offerings will be integrated into the XRHealth offerings, which the company says will add scientifically proven methods to its portfolio that help manage chronic pain and behavioral health conditions. It will also introduce RealizedCare's triage tool aimed at optimizing personalized patient care. .
RealizedCare 的产品将被整合到 XRHealth 的产品中,该公司表示,此举将为其产品组合增加经过科学验证的方法,有助于管理慢性疼痛和行为健康状况。此外,还将引入 RealizedCare 的分诊工具,旨在优化个性化的患者护理。
XRHealth says that thanks to the acquisition, it is now the 'largest AI-driven therapeutic XR platform worldwide.'
XRHealth表示,通过此次收购,它现在是“全球最大的AI驱动的治疗性XR平台”。
Aaron Gani
艾伦·加尼
, RealizedCare founder and CEO and chairman of the board of directors at the
,RealizedCare创始人、首席执行官兼董事会主席
Digital Therapeutics Alliance
数字疗法联盟
, will become general manager of XRHealth U.S.
,将成为XRHealth美国公司的总经理。
'We are thrilled to become a part of XRHealth’s groundbreaking digital therapeutics platform,' Gani said in a statement. 'By integrating our triage tool with XRHealth’s cutting-edge XR and mixed reality capabilities, we can expand access to evidence-based, value-based care solutions, helping more individuals manage chronic pain and mental health conditions.'.
“我们很高兴成为XRHealth开创性数字治疗平台的一部分,”加尼在一份声明中表示。“通过将我们的分诊工具与XRHealth尖端的XR和混合现实功能相结合,我们可以扩大基于证据、基于价值的护理解决方案的可及性,帮助更多人管理慢性疼痛和心理健康问题。”
THE LARGER TREND
更大的趋势
In November, XRHealth
在十一月,XRHealth
announced
宣布
it acquired
它获得了
NeuroReality
神经现实
, a cognitive training virtual reality platform. The acquisition included all of NeuroReality's assets, including its flagship rehabilitation product, Koji's Quest.
,一个认知训练虚拟现实平台。此次收购包括NeuroReality的所有资产,包括其旗舰康复产品《Koji's Quest》。
In 2023, XRHealth acquired
2023年,XRHealth收购了
Barcelona-based
巴塞罗那的
Amelia Virtual Care
阿米莉亚虚拟护理
, a VR platform for mental health professionals. The company allowed providers to connect directly with patients via the platform but has since pulled out of the direct-to-provider space.
,一个面向心理健康专业人士的VR平台。该公司曾允许供应商通过该平台直接与患者联系,但后来已退出了直接面向供应商的领域。
XRHealth
XR健康
secured
安全的
$6 million in funding
600万美元的资金
last year, two years after scoring
去年,两年后得分
$10 million in funding
1000万美元的资金
. In 2020, the company garnered
在2020年,该公司获得了
$7 million in funding
700万美元的资金
and a
和一个
$450,000 grant
45万美元补助金
from the Israeli Innovation Authority to provide hospitals in Israel with telehealth services to combat the effects of COVID-19.
来自以色列创新局,为以色列的医院提供远程医疗服务,以应对新冠疫情的影响。
In 2022,
2022年,
BehaVR merged
BehaVR合并
with Oxford University spin-out
与牛津大学分拆公司
OxfordVR
牛津VR
, a VR platform for severe mental health issues. The companies united under the BehaVR brand and garnered $13 million in Series B funding to support the merger.
,一个针对严重心理健康问题的VR平台。这些公司联合在BehaVR品牌下,并获得了1300万美元的B轮融资以支持此次合并。
BehaVR and Japanese company Sumitomo Pharma
BehaVR 和日本住友制药公司
signed a potential $163 million deal in 2021 to develop VR therapies aimed at treating social anxiety disorder, major depressive disorder and generalized anxiety disorder.
2021年签署了一项潜在价值1.63亿美元的协议,用于开发针对社交焦虑症、重度抑郁症和广泛性焦虑症的VR疗法。
The partnership
伙伴关系
included a multi-DTx deal that was one of the largest collaborations between a pharma company and a VR firm in history.
包括一项多DTx交易,这是制药公司与VR公司之间历史上最大的合作之一。
Tags:
标签:
XRHealth
XR健康
,
,
RealizedCare
实现关怀
,
,
virtual reality
虚拟现实
,
,
medical XR
医学XR
,
,
extended reality
扩展现实
More regional news
更多地区新闻
Exclusive: Keebler Health secures $6M for product development
独家:Keebler Health 获得 600 万美元用于产品开发
By
通过
Anthony Vecchione
安东尼·维奇奥内
February 18, 2025
2025年2月18日
Exclusive: DoseSpot launches Connect to give patients Rx price transparency
独家:DoseSpot 推出 Connect,为患者提供处方药价格透明度
By
通过
Jessica Hagen
杰西卡·哈根
February 17, 2025
2025年2月17日
Abridge secures $250M for core research and development
Abridge 获得 2.5 亿美元用于核心研发
By
通过
Anthony Vecchione
安东尼·维奇奥内
February 17, 2025
2025年2月17日